Grant or Restriction
Specify whether the mark is assigned, licensed, or restricted, including precise goods/services and permitted channels to prevent ambiguity.
A clear, signed agreement reduces uncertainty about rights, avoids future litigation, preserves goodwill, and provides an enforceable record for courts or the USPTO. It can include confidentiality, assignment or license terms, and procedures for recording assignments or coexistence arrangements.
Ensure the signatories have authority to bind their organizations, and that counsel reviews restrictions affecting future brand use.
Often signs for corporate parties when settlement alters licensing, assigns rights, or imposes long-term obligations; counsel usually prepares and reviews the final text before execution to ensure enforceability.
A designated executive or manager with delegated authority may sign for smaller entities or licensees; confirm written signing authority and include a title line in the signature block.
Specify whether the mark is assigned, licensed, or restricted, including precise goods/services and permitted channels to prevent ambiguity.
State effective date, term length, renewal mechanics, termination triggers, and consequences for breach or insolvency.
When licensing, define minimum quality standards, approval processes, and audit rights to preserve mark strength.
Protect settlement terms and sensitive business information with clear confidentiality and permitted disclosure clauses.
Identify governing law, forum, and whether mediation or arbitration is required before litigation to limit future costs.
Require steps to record assignments or licenses with the USPTO and timelines for doing so to preserve public notice.
Each party should represent authority to sign and non-infringement of third-party rights to reduce later challenges.
Allocate responsibility for third-party claims and specify defense duties and limits to financial exposure.
Define how notices must be sent and whether public statements about the settlement are permitted.
Require written amendments signed by authorized representatives to prevent unintended oral modifications.
All parties sign and date the agreement and exchange executed copies.
Submit assignment or license recordation to the USPTO if required by the agreement.
Implement any permitted use changes, quality controls, or label updates.
Track term expirations, renewal options, or ongoing royalty payments.
10–30 days for initial counterproposal or acceptance
30–90 days to reach a settlement in most cases
File with USPTO within 30–90 days after execution
30–120 days to implement labeling or packaging changes
Ongoing during term; review annually for compliance
| Issue | Opposition Proceeding | Settlement Agreement |
|---|---|---|
| Filing forum | ttab administrative record | private contract, possible court filing |
| Public record effect | federal record showing opposition | may be confidential unless recorded |
| Typical timeline | months to years | weeks to months |
| Control over terms | limited to ttab remedies | parties craft bespoke terms |
| signNow | DocuSign | Adobe Sign | PandaDoc | HelloSign | |
|---|---|---|---|---|---|
| Starting Price | $8/user/mo | $15/user/mo | $14/user/mo | $19/user/mo | $15/user/mo |
| Free Trial | 7-day free trial | No free trial listed | No free trial listed | Limited free offering | Limited free offering |
| Bulk Send | Yes | Yes | Yes | Yes | Yes |
| Audit Trail | Yes | Yes | Yes | Yes | Yes |
| HIPAA Compliant | Yes | Yes | Yes | No | No |
| Envelope Cap | No envelope cap | 100 envelopes/user/year | Varies by plan | Varies by plan | Varies by plan |